The paucity of evidence supporting screening for stages 1–3 CKD in asymptomatic patients with or without risk factors

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 11, 2014, Pages 1993-1995

  Qaseem, Amir ^a   Wilt, Timothy J ^b   Cooke, Molly ^c   Denberg, Thomas D ^d  

^a AMERICAN COLLEGE OF PHYSICIANS   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CARILION CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ALBUMINURIA; ARTICLE; ASYMPTOMATIC DISEASE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COST CONTROL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; END STAGE RENAL DISEASE; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HUMAN; HYPERTENSION; MACROALBUMINURIA; MASS SCREENING; MICROALBUMINURIA; PRACTICE GUIDELINE; PROTEINURIA; RISK FACTOR; ECONOMICS; LABORATORY DIAGNOSIS; RENAL INSUFFICIENCY; RISK ASSESSMENT; UNNECESSARY PROCEDURE;

ASYMPTOMATIC DISEASES; FALSE POSITIVE REACTIONS; HUMANS; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; RENAL INSUFFICIENCY; RISK ASSESSMENT; RISK FACTORS; UNNECESSARY PROCEDURES;

EID: 84923935164     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02940314     Document Type: Article

References (13)

1. Qaseem A, Hopkins RH Jr, Sweet DE, Starkey M, Shekelle P; Clinical Guidelines Committee of the American College of Physicians: Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians. Ann Intern Med 159: 835–847, 2013
2. Qaseem A, Forland F, Macbeth F, Ollenschlager G, Phillips S, van derWees P; Board of Trustees of the Guidelines International Network: Guidelines International Network: Toward international standards for clinical practice guidelines. Ann Intern Med 156: 525–531, 2012
3. Wilson JMG, Jungner G: Principles and Practice of Screening for Disease, Geneva, Switzerland, World Health Organization, 1968
4. Rose G, Barker DJ: Epidemiology for the uninitiated. Screening. BMJ 2: 1417–1418, 1978
5. Fink HA, Ishani A, Taylor BC, Greer NL, MacDonald R, Rossini D, Sadiq S, Lankireddy S, Kane RL, Wilt TJ; Minnesota Evidence- Based Practice Center: Chronic Kidney Disease Stages 1–3: Screening, Monitoring, and Treatment. Comparative Effectiveness Reviews, No. 37, AHRQ Publication No. 11(12)-EHC075- EF, Rockville, MD, Agency for Healthcare Research and Quality, 2012
6. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604–612, 2009
7. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1–12, 2003
8. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS: Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348: 2285–2293, 2003
9. Moyer VA; U.S. Preventive Services Task Force: Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 157: 567–570, 2012
10. Owens DK, Qaseem A, Chou R, Shekelle P; Clinical Guidelines Committee of the American College of Physicians: High-value, cost-conscious health care: Concepts for clinicians to evaluate the benefits, harms, and costs of medical interventions. Ann Intern Med 154: 174–180, 2011
11. Institute of Medicine: Clinical Practice Guidelines We Can Trust, Washington, DC, National Academies Press, 2011
12. National Collaborating Centre for Chronic Conditions: Chronic Kidney Disease: National Clinical Guideline for Early Identification and Management in Adults in Primary and Secondary Care, London, Royal College of Physicians, 2008
13. Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 3: 1–150, 2013